Information  X 
Enter a valid email address
  Print          More announcements

Friday 10 September, 2021

Irish Takeover Panel

Disclosure Table

RNS Number : 4170L
Irish Takeover Panel
10 September 2021

Disclosure Table  

The following companies are deemed to be in an offer period for the purposes of disclosure under the Rules of the Irish Takeover Panel:


Offeree:   Strongbridge Biopharma plc

Offer period commenced:  24 May 2021

$0.01 ordinary shares; ISIN: IE00BYZ5XL97; NSI: 67,828,952

Offeror:   Xeris Pharmaceuticals, Inc.

$0.001 common stock; ISIN: US98422L1070; NSI: 66,497,370






Irish Takeover Panel  10 September 2021

Lower Ground Floor

7 6 Merrion Square

Dublin D02 X4T1


Telephone:  + 353-1-678 9020 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t